Core Insights - Colgate-Palmolive Company reported strong fourth-quarter 2025 results, with both revenue and earnings exceeding expectations, driven by solid pricing and brand strength in oral care and pet nutrition [1][2] Financial Performance - Earnings per share (EPS) on a non-GAAP basis were 95 cents, a 4% increase year-over-year, surpassing the Zacks Consensus Estimate of 91 cents [2] - Net sales reached $5.230 billion, up 5.8% from the previous year, also exceeding the Zacks Consensus Estimate of $5.088 billion [2] - Organic sales grew by 2.2%, despite a 0.9% negative impact from reduced private-label pet volume, with a positive currency effect of 3.1% [2] Segment Analysis - North America: Net sales decreased by 1.5% year-over-year, with a 2.3% drop in volume offset by a 0.5% rise in pricing [11] - Latin America: Net sales increased by 12.8% year-over-year, driven by a 4.2% rise in pricing and a 2.3% increase in volume [12] - Europe: Net sales rose by 9.8% year-over-year, supported by a 1% increase in pricing and a positive currency effect of 8.1% [12] - Asia Pacific: Net sales declined by 0.3% year-over-year, with a 2.2% drop in volume, but a 2.3% rise in pricing helped offset losses [13] - Africa/Eurasia: Net sales improved by 15% year-over-year, driven by 9.1% growth in pricing and a 4.7% favorable currency effect [13] - Hill's Pet Nutrition: Net sales increased by 4.9% year-over-year, benefiting from a 3% rise in pricing [14] Profitability Metrics - Base business gross profit was $3.15 billion, a 5.5% increase from the prior year, with a gross profit margin of 60.2%, down 10 basis points [8] - Adjusted SG&A expenses totaled $1.98 billion, up 4.5% year-over-year, maintaining a percentage of sales at 38.3% [9] - Adjusted operating profit was $1.11 billion, a 3% increase year-over-year, with an operating profit margin of 21.2%, down 50 basis points [10] Cash Flow and Shareholder Returns - Colgate ended Q4 2025 with cash and cash equivalents of $1.28 billion and total debt of $7.9 billion [15] - The company returned $2.9 billion to shareholders through dividends and share repurchases over the past 12 months [15] 2026 Outlook - Colgate anticipates net sales growth of 2-6% for 2026, with organic sales projected to increase by 1-4% [16] - Management expects gross margin expansion and double-digit growth in EPS for 2026 [17]

Core Insights - Colgate-Palmolive Company (NYSE:CL) is recognized as one of the 12 Best Dividend Aristocrat Stocks to invest in currently [1] - The company is a leading manufacturer in the consumer products sector, particularly in Oral Care, with significant market shares [2] - Colgate-Palmolive emphasizes sustainability in its operations, implementing initiatives like recyclable toothpaste tubes [3] - The company has a long history of increasing dividends, with a current quarterly dividend of $0.52 per share and a dividend yield of 2.62% [4] Company Overview - Colgate-Palmolive operates in more than 200 countries, showcasing a strong global presence [3] - The company holds a 40.9% share of the global toothpaste market and a 31.9% share of the manual toothbrush market [2] Sustainability Initiatives - Sustainability is a fundamental aspect of Colgate-Palmolive's strategy, with clear environmental goals and initiatives aimed at reducing plastic waste [3] Dividend Performance - The company has increased its dividends for 62 consecutive years, reinforcing its status as a reliable dividend payer [4] - The current dividend yield stands at 2.62% as of September 26 [4]

Core Insights - Colgate-Palmolive Company (CL) reported strong second-quarter 2025 results, with both revenue and earnings exceeding expectations and showing year-over-year improvement [1][2][8] - The company is focusing on enhancing its capabilities in digital, data, and analytics to strengthen competitive advantages and profitability [1] Financial Performance - On a non-GAAP basis, earnings per share (EPS) were $0.92, a 1% increase from the previous year, surpassing the Zacks Consensus Estimate of $0.89 [2][8] - Net sales reached $5.11 billion, a 1% increase from the prior year, exceeding the Zacks Consensus Estimate of $5.05 billion [2][8] - Organic sales grew by 1.8%, despite a 0.6% negative impact from reduced private-label pet volume and a 1% adverse effect from foreign exchange [2][8] Segment Analysis - North America's net sales, accounting for 20% of total sales, decreased by 1% year over year, attributed to a 0.5% drop in pricing and a 0.4% decline in volume [10] - Latin America's net sales, representing 24% of total sales, fell by 4.8% year over year, with an 8.2% negative currency impact overshadowing a 3% pricing gain [10] - Europe's net sales increased by 7.8% year over year, driven by a 2.2% rise in pricing and a 5.7% positive currency effect [11] - The Asia Pacific segment's net sales rose by 0.8% year over year, with a 1.6% drop in volume offset by a 1.6% increase in pricing [11] - Africa/Eurasia's net sales improved by 8% year over year, supported by a 4.3% growth in volume and a 3.4% increase in pricing [12] - Hill's Pet Nutrition's net sales increased by 3.8% year over year, benefiting from a 2.9% rise in pricing [12] Profitability Metrics - The base business gross profit was $3.07 billion, a slight decrease of 0.2% from the previous year, with a gross profit margin of 60.1%, down 70 basis points [6][9] - Adjusted operating profit was $1.09 billion, a decline of 3% year over year, with an adjusted operating profit margin of 21.3%, down 80 basis points [9] Cash Flow and Shareholder Returns - Colgate ended the second quarter with cash and cash equivalents of $1.22 billion and total debt of $8.8 billion [13] - The company generated $1.5 billion in net cash from operating activities for the first half of 2025 and returned $880 million to shareholders through dividends [13] Future Outlook - Colgate anticipates continued uncertainty and volatility in global markets, projecting organic sales growth at the lower end of the previous 2-4% guidance range [14][16] - The company expects net sales to grow in low single digits, with a flat to low-single-digit adverse impact from foreign exchange [15]

Core Viewpoint - Colgate-Palmolive Company reported first-quarter 2025 results with earnings and sales exceeding expectations, driven by organic sales growth, strong volume and pricing performance, and gross profit margin expansion [1][2][3] Financial Performance - Earnings on a Base Business basis were 91 cents per share, a 6% increase year over year, surpassing the Zacks Consensus Estimate of 86 cents [2] - Net sales totaled $4,911 million, a 3.1% decline from the previous year but above the Zacks Consensus Estimate of $4,855 million; organic sales grew by 1.4% despite a 4.4% negative impact from foreign exchange [3][4] - Gross profit was $2,987 million, down from $3,039 million year over year, but gross profit margin expanded by 80 basis points to 60.8% [6] - Operating profit increased to $1,076 million from $1,047 million year over year, with an operating profit margin expansion of 120 basis points to 21.9% [7] Segment Performance - North America's net sales, accounting for 20% of total sales, decreased by 3.6% year over year; Latin America's net sales fell by 8.7% due to currency impacts, although organic sales rose by 4% [8] - Europe's net sales increased by 2.5% year over year, driven by volume and pricing gains, while the Asia Pacific segment saw a 5% decline in net sales [9] - Africa/Eurasia's net sales dipped by 1.5% year over year, but organic sales advanced by 1.8% [10] - Hill's Pet Nutrition's net sales improved by 1.5% year over year, with a 3.2% rise in pricing [11] Cash Flow and Debt - The company ended the first quarter with cash and cash equivalents of $1,112 million and total debt of $8,269 million; net cash provided by operating activities was $600 million [12] 2025 Outlook - Colgate projects low single-digit growth in net sales, with an anticipated adverse impact from foreign exchange; organic sales growth is now expected to be between 2-4% [13][15] - The company anticipates earnings per share to increase in low single digits, with gross profit margin and advertising investment remaining stable as a percentage of sales [15][16] Stock Performance - Colgate's shares have risen by 2.1% over the past three months, contrasting with a 1.9% decline in the industry [17]